LYFE-TR

LYFE-TR is a synthetic peptide acting as a dual agonist for GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Known as a "twincretin," it mimics gut hormones to improve blood sugar, increase satiety, and reduce appetite, often yielding higher weight loss than single-agonist therapies. Sometimes called the dual-pathway metabolic support (GLP/GIP activity), may help enhances fat loss signaling, may also reduce appetite and food cravings and possibly supports insulin sensitivity. 

This is a synthetic peptide supplied for qualified laboratory research use only. This material is intended for analytical characterization, assay development, method validation, and other non-clinical research applications conducted by properly trained professionals in controlled settings.

COA: Product information is provided for compound identification and laboratory reference purposes only. Any use must be limited to lawful research activities and handled in accordance with applicable institutional, regulatory, and safety requirements.

RUO: This material is supplied strictly for research use only and is not intended for human or veterinary use, diagnostic use, therapeutic use, or food use.